Literature DB >> 15203988

DC-based cancer vaccines: lessons from clinical trials.

J D Brody1, E G Engleman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15203988     DOI： 10.1080/14653240410005267

Source DB:  PubMed          Journal:  Cytotherapy        ISSN： 1465-3249            Impact factor:   5.414


× No keyword cloud information.
  4 in total

1.  Exosomes derived from rAAV/AFP-transfected dendritic cells elicit specific T cell-mediated immune responses against hepatocellular carcinoma.

Authors:  Jieyu Li; Shenglan Huang; Zhifeng Zhou; Wansong Lin; Shuping Chen; Mingshui Chen; Yunbin Ye
Journal:  Cancer Manag Res       Date:  2018-10-29       Impact factor: 3.989

2.  Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity.

Authors:  Jingbo Zhai; Wei Gao; Leheng Zhao; Zhipeng Gao; Xuefeng Jiang; Changlong Lu
Journal:  Exp Ther Med       Date:  2018-10-11       Impact factor: 2.447

3.  Comparing the ability of freshly generated and cryopreserved dendritic cell vaccines to inhibit growth of breast cancer in a mouse model.

Authors:  Ammu Kutty Radhakrishnan; Geok Choo Sim; Soon Keng Cheong
Journal:  Biores Open Access       Date:  2012-10

Review 4.  Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.

Authors:  Ilse Van Brussel; Zwi N Berneman; Nathalie Cools
Journal:  Mediators Inflamm       Date:  2012-07-18       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.